Press Releases
Egalet Announces OXAYDO® Receives Pharmaceutical Composition Patent Protection Through 2024
Egalet Corporation , a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,announced the issuance...
Press Releases
Zimmer Biomet Announces Launch of the Comprehensive® Vault Reconstruction System – the First Commercially Available Patient-matched Glenoid ImplantÂ
Zimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare,announced the launch of the Comprehensive® Vault Reconstruction System (VRS),the first patient-matched glenoid implant...
Press Releases
Largest Ever PACK EXPO Exceeds Highest of Expectations
On the 60th Anniversary of its debut, PACK EXPO International and the co-located Pharma EXPO served as the world’s largest and most comprehensive processing...
Articles
Making the right choice for DataMatrix pharmaceutical packaging serialization
The impact of the DataMatrix code in the pharmaceutical industry has been immense. Offering high standards of data quantity and security, this two-dimensional matrix...
Drug Research
Global market will reach $26 billion by 2020, says GBI Research
The global market for drug delivery technologies will rise from $20 billion in 2015 to around $26 billion by 2020, according to business intelligence...
Drug Research
Neos Therapeutics Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug Candidate, Amphetamine, for the Treatment of ADHD
Neos Therapeutics a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of attention-deficit hyperactivity disorder (ADHD), announced that...
Drug Research
Ra Pharmaceuticals Receives Orphan Drug Designation in the European Union for RA101495 for Treatment of Paroxysmal Nocturnal Hemoglobinuria
Ra Pharmaceuticals , a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for diseases of complement dysregulation, announced that the EC...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read